US court backs Sanofi and Regeneron in Amgen suit
29-08-2019
Sanofi victorious at Fed Circ in prostate cancer drug dispute
15-08-2019
German Court rules Sanofi’s Praluent infringes Amgen patent
12-07-2019
Keitma / Shutterstock.com
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Amgen, Sanofi, German Federal Court of Justice, Praluent, Repatha, high cholesterol, patent infringement
